John Libbey Eurotext

European Cytokine Network

Chemokine and chemokine receptor patterns in patients with benign and malignant salivary gland tumors: a distinct role for CCR7 Volume 28, numéro 1, March 2017

Illustrations

  • Figure 1
  • Figure 2
  • Figure 3
  • Figure 4

Tableaux

Auteurs
1 Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
2 Department of Pathology, Khalili Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
3 Otolaryngology Research Center, Department of Otolaryngology, Shiraz University of Medical Sciences, Shiraz, Iran
4 Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
* Correspondence: A ghaderi, Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran M Razmkhah, Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
  • Mots-clés : salivary gland tumors (SGTs), chemokine, chemokine receptor
  • DOI : 10.1684/ecn.2017.0388
  • Page(s) : 27-35
  • Année de parution : 2017

Background

To explore the molecular mechanisms involved in pathophysiology of malignant and benign salivary gland tumors (SGTs), we investigated main tumor-inducing chemokines and chemokine receptors, CXCL12/CXCR4/ACKR3 (CXCR7), CXCR3/CXCL10, CCR5/CCL5, CCL21/CCR7, CCL2, CCR4, CXCR5, CCR6, and CXCL8 in tumor tissues.